{"transactions":[{"id":898764,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-02-19T02:30:08.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":28250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents an RSU award, one-third of which shall vest on February 17, 2027 with the remaining 2/3  two-thirds of the RSUs vesting in equal annual installments over the following two years. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents an RSU award, one-third of which shall vest on February 17, 2027 with the remaining 2/3  two-thirds of the RSUs vesting in equal annual installments over the following two years. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":28250,"derivative":{"underlying":"Common Stock","underlying_shares":28250},"source":{"system":"sec-edgar","filing":"0001466794-26-000003","document":"form4-02182026_090205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872912/000146679426000003/form4-02182026_090205.xml","form_type":"4"}},{"id":898763,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-19T02:30:08.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":56500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 17, 2026 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended)."}],"balance_after":56500,"derivative":{"exercise_price":9.4,"expiration_date":"2036-02-17","underlying":"Common Stock","underlying_shares":56500},"source":{"system":"sec-edgar","filing":"0001466794-26-000003","document":"form4-02182026_090205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000146679426000003/form4-02182026_090205.xml","form_type":"4"}},{"id":1112544,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-13T21:22:47.000Z","date":"2025-06-12","kind":"exercise","planned":false,"acquired":false,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 12, 2024 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended)."}],"balance_after":58500,"derivative":{"exercise_price":4.78,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001415889-25-017260","document":"form4-06132025_090639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872912/000141588925017260/form4-06132025_090639.xml","form_type":"4"}},{"id":1112543,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-06-13T21:22:47.000Z","date":"2025-06-12","kind":"exercise","planned":false,"acquired":true,"shares":42000,"price":4.78,"value":200760.0,"ownership":{"direct":true},"balance_after":168882,"source":{"system":"sec-edgar","filing":"0001415889-25-017260","document":"form4-06132025_090639.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000141588925017260/form4-06132025_090639.xml","form_type":"4"}},{"id":1279402,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T00:06:42.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":113000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 7, 2025 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended)."}],"balance_after":113000,"derivative":{"exercise_price":16.25,"expiration_date":"2035-02-07","underlying":"Common Stock","underlying_shares":113000},"source":{"system":"sec-edgar","filing":"0001415889-25-003404","document":"form4-02082025_120239.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000141588925003404/form4-02082025_120239.xml","form_type":"4"}},{"id":1570872,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-19T21:03:00.000Z","date":"2024-03-19","kind":"grant","planned":false,"acquired":true,"shares":26882,"price":3.72,"value":100001.04,"ownership":{"direct":true},"balance_after":126882,"source":{"system":"sec-edgar","filing":"0001415889-24-008588","document":"form4-03192024_090356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000141588924008588/form4-03192024_090356.xml","form_type":"4"}},{"id":1644311,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-14T21:46:51.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":100500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 12, 2024 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended)."}],"balance_after":100500,"derivative":{"exercise_price":4.78,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":100500},"source":{"system":"sec-edgar","filing":"0001415889-24-003763","document":"form4-02142024_090238.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000141588924003763/form4-02142024_090238.xml","form_type":"4"}},{"id":1711599,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-14T21:20:16.000Z","date":"2023-12-12","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":3,"value":120000.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001209191-23-058628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000120919123058628/doc4.xml","form_type":"4"}},{"id":1735361,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-11-20T21:22:23.000Z","date":"2023-11-16","kind":"purchase","planned":false,"acquired":true,"shares":60000,"price":2.48,"value":148800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.41 to $2.49 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001209191-23-056054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000120919123056054/doc4.xml","form_type":"4"}},{"id":2314150,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-30T20:32:28.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This amendment is being filed to correct the date of grant and the exercise price for the stock option reported on a Form 4 filed by the reporting person on March 24, 2022. This option became effective on March 30, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option are scheduled to vest in equal monthly installments through March 30, 2026."}],"balance_after":150000,"derivative":{"exercise_price":0.48,"expiration_date":"2032-03-29","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-22-012857","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466794/000089924322012857/doc4a.xml","form_type":"4/A","original_submission_date":"2022-03-24"}},{"id":2318895,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-24T19:43:19.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 22, 2022. The shares underlying the option are scheduled to vest in equal monthly installments through March 22, 2026."}],"balance_after":150000,"derivative":{"exercise_price":0.44,"expiration_date":"2032-03-21","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-22-012144","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466794/000089924322012144/doc4.xml","form_type":"4"}},{"id":2663637,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T19:51:38.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2021. The shares underlying the option are scheduled to vest as to 25% of the shares on June 15, 2022 and thereafter in equal monthly installments through June 15, 2025."}],"balance_after":400000,"derivative":{"exercise_price":1.29,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000899243-21-024524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466794/000089924321024524/doc4.xml","form_type":"4"}},{"id":3291568,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-04T16:33:11.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 31, 2020. The shares underlying the option are scheduled to vest in equal monthly installments over four years from January 31, 2020."}],"balance_after":225000,"derivative":{"exercise_price":0.67,"expiration_date":"2030-01-30","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000899243-20-002807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466794/000089924320002807/doc4.xml","form_type":"4"}},{"id":3433151,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-08-20T16:17:13.000Z","date":"2019-08-16","kind":"purchase","acquired":true,"shares":75000,"price":0.5927,"value":44452.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5890 per share to $0.5980 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0000899243-19-022104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466794/000089924319022104/doc4.xml","form_type":"4"}},{"id":3553757,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-17T18:43:50.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on April 15, 2019. The shares underlying the option are scheduled to vest in equal monthly installments over four years from April 15, 2019."}],"balance_after":100000,"derivative":{"exercise_price":1.75,"expiration_date":"2029-04-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-19-010815","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466794/000089924319010815/doc4.xml","form_type":"4"}},{"id":3772694,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":66025,"kind":"person","name":"Vukovic Vojo","position":1,"cik":"0001466794","reported_name":"Vukovic Vojo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-11-06T18:18:34.000Z","date":"2018-11-05","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on November 5, 2018.  The shares underlying the option are scheduled to vest as to 25% of the shares on November 5, 2019 and thereafter in equal monthly installments through November 5, 2022."}],"balance_after":150000,"derivative":{"exercise_price":2.16,"expiration_date":"2028-11-04","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-18-028339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466794/000089924318028339/doc4.xml","form_type":"4"}}]}